Johan Wedell-Wedellsborg, Director at Y-mAbs Therapeutics, Inc. (YMAB), sold 72,400 shares at $34.15 ($2.5M) on 2021-06-07, disclosed to the SEC on 2021-06-09.
Open-market sale of $2.5M YMAB by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| YMAB | BUY | 2023-12-01 | $619K | — | Filing → |
| YMAB | BUY | 2023-11-29 | $1.0M | — | Filing → |
| YMAB | BUY | 2023-05-17 | $982K | — | Filing → |